The pharmacology and formulation of paliperidone extended release.
about
A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorderAntipsychotic dosing: found in translationThe efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese populationClinical improvement, relapse and treatment adherence with paliperidone palmitate 1-month formulation: 1-year treatment in a naturalistic outpatient setting.Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia.Elevated risperidone serum concentrations during acute inflammation, two cases.
P2860
The pharmacology and formulation of paliperidone extended release.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The pharmacology and formulation of paliperidone extended release.
@en
type
label
The pharmacology and formulation of paliperidone extended release.
@en
prefLabel
The pharmacology and formulation of paliperidone extended release.
@en
P2093
P2860
P356
P1476
The pharmacology and formulation of paliperidone extended release.
@en
P2093
Erin M MacKenzie
Glen B Baker
James A Chue
Pierre S Chue
P2860
P304
P356
10.1586/ERN.12.138
P577
2012-12-01T00:00:00Z